Pressure BioSciences, Inc. (PBIO)
OTCMKTS
· Delayed Price · Currency is USD
0.0040
0.00 (0.00%)
Jan 23, 2025, 7:00 PM EST
Pressure BioSciences Employees
As of December 31, 2023, Pressure BioSciences had 16 total employees, including 15 full-time and 1 part-time employees. The number of employees decreased by 2 or -11.11% compared to the previous year.
Employees
16
Change (1Y)
-2
Growth (1Y)
-11.11%
Revenue / Employee
$99,151
Profits / Employee
-$2,288,704
Market Cap
163.87K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 109 |
SANUWAVE Health | 31 |
Pressure BioSciences News
- 7 months ago - Pressure BioSciences Partners with Vita-Forte, Largest Global Supplier of Freeze-Dried Acai, to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray - GlobeNewsWire
- 7 months ago - Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET - GlobeNewsWire
- 8 months ago - Pressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ET - GlobeNewsWire
- 10 months ago - Pressure BioSciences' Uncle Bud's Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection” - GlobeNewsWire
- 1 year ago - Uncle Bud's Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc. - GlobeNewsWire
- 1 year ago - Pressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing - GlobeNewsWire
- 1 year ago - Pressure BioSciences, Inc. (PBIO) Acquisition of Uncle Bud's Conference Call (Transcript) - Seeking Alpha
- 1 year ago - Uncle Bud's to Launch New Premium Health and Wellness Products Leveraging Pressure BioSciences UltraShear Processing for Revolutionary Product Effectiveness - GlobeNewsWire